Hypertension Impact Factor
Hypertension is a month to month peer-assessed logical diary that was built up in 1979. It is distributed for the benefit of the American Heart Association by Lippincott Williams and Wilkins. The editorial manager in-boss is Anna F. Dominiczak. The diary distributes unique original copies, welcomed
audit synopses, welcomed case-based surveys, late examination features, welcomed brief critiques, logical or specialized instructional exercises, letters to the supervisor, and novel discoveries of uncommon intrigue. It covers all parts of examination on hypertension, including pathophysiology, pulse guideline, clinical treatment, and prevention.High circulatory strain is delegated essential (fundamental)
hypertension or auxiliary hypertension. Around 90–95% of cases are essential, characterized as
hypertension because of vague way of life and hereditary variables. Way of life factors that expansion the hazard remember abundance salt for the eating routine, overabundance body weight, smoking, and liquor use. The staying 5–10% of cases are arranged as optional hypertension, characterized as
hypertension because of a recognizable reason, for example, ceaseless kidney ailment, narrowing of the kidney courses, an endocrine issue, or the utilization of anti-conception medication pills.
High Impact List of Articles
-
Data monitoring committees in clinical trials: best practice, complexities and considerations
Simon Day
Editorial: Clinical Investigation
-
Data monitoring committees in clinical trials: best practice, complexities and considerations
Simon Day
Editorial: Clinical Investigation
-
Data monitoring committees in clinical trials: best practice, complexities and considerations
Simon Day
Editorial: Clinical Investigation
-
Data monitoring committees in clinical trials: best practice, complexities and considerations
Simon Day
Editorial: Clinical Investigation
-
Data monitoring committees in clinical trials: best practice, complexities and considerations
Simon Day
Editorial: Clinical Investigation
-
Data monitoring committees in clinical trials: best practice, complexities and considerations
Simon Day
Editorial: Clinical Investigation
-
The importance of budgeting in clinical trials and how a budget can prevent billing errors
Mitchell Appleson
Editorial: Clinical Investigation
-
The importance of budgeting in clinical trials and how a budget can prevent billing errors
Mitchell Appleson
Editorial: Clinical Investigation
-
The importance of budgeting in clinical trials and how a budget can prevent billing errors
Mitchell Appleson
Editorial: Clinical Investigation
-
The importance of budgeting in clinical trials and how a budget can prevent billing errors
Mitchell Appleson
Editorial: Clinical Investigation
-
The importance of budgeting in clinical trials and how a budget can prevent billing errors
Mitchell Appleson
Editorial: Clinical Investigation
-
The importance of budgeting in clinical trials and how a budget can prevent billing errors
Mitchell Appleson
Editorial: Clinical Investigation
-
News from the European Society of Cardiology Congress 2011
News and Views: Clinical Investigation
-
News from the European Society of Cardiology Congress 2011
News and Views: Clinical Investigation
-
News from the European Society of Cardiology Congress 2011
News and Views: Clinical Investigation
-
News from the European Society of Cardiology Congress 2011
News and Views: Clinical Investigation
-
News from the European Society of Cardiology Congress 2011
News and Views: Clinical Investigation
-
News from the European Society of Cardiology Congress 2011
News and Views: Clinical Investigation
-
Current and emerging therapies for stroke prophylaxis in
atrial fibrillation
Eric TS Lim, Jonathan Yap, Chee Tang Chin
Review Article: Clinical Investigation
-
Current and emerging therapies for stroke prophylaxis in
atrial fibrillation
Eric TS Lim, Jonathan Yap, Chee Tang Chin
Review Article: Clinical Investigation
-
Current and emerging therapies for stroke prophylaxis in
atrial fibrillation
Eric TS Lim, Jonathan Yap, Chee Tang Chin
Review Article: Clinical Investigation
-
Current and emerging therapies for stroke prophylaxis in
atrial fibrillation
Eric TS Lim, Jonathan Yap, Chee Tang Chin
Review Article: Clinical Investigation
-
Current and emerging therapies for stroke prophylaxis in
atrial fibrillation
Eric TS Lim, Jonathan Yap, Chee Tang Chin
Review Article: Clinical Investigation
-
Current and emerging therapies for stroke prophylaxis in
atrial fibrillation
Eric TS Lim, Jonathan Yap, Chee Tang Chin
Review Article: Clinical Investigation
-
Clinical evidence of the role of belimumab in the treatment of systemic lupus erythematosus
Ricard Cervera, Gerard Espinosa
Review Article: Clinical Investigation
-
Clinical evidence of the role of belimumab in the treatment of systemic lupus erythematosus
Ricard Cervera, Gerard Espinosa
Review Article: Clinical Investigation
-
Clinical evidence of the role of belimumab in the treatment of systemic lupus erythematosus
Ricard Cervera, Gerard Espinosa
Review Article: Clinical Investigation
-
Clinical evidence of the role of belimumab in the treatment of systemic lupus erythematosus
Ricard Cervera, Gerard Espinosa
Review Article: Clinical Investigation
-
Clinical evidence of the role of belimumab in the treatment of systemic lupus erythematosus
Ricard Cervera, Gerard Espinosa
Review Article: Clinical Investigation
-
Clinical evidence of the role of belimumab in the treatment of systemic lupus erythematosus
Ricard Cervera, Gerard Espinosa
Review Article: Clinical Investigation
Relevant Topics in Clinical